SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-021150
Filing Date
2017-04-20
Accepted
2017-04-20 09:00:24
Documents
5
Period of Report
2017-04-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v464548_8k.htm 8-K 24568
2 EXHIBIT 10.1 v464548_ex10-1.htm EX-10.1 26007
3 EXHIBIT 99.1 v464548_ex99-1.htm EX-99.1 12223
4 GRAPHIC image_001.jpg GRAPHIC 2627
5 GRAPHIC image_002.jpg GRAPHIC 4113
  Complete submission text file 0001144204-17-021150.txt   73701
Mailing Address 1600 BROADWAY SUITE 950 DENVER CO 80202
Business Address 1600 BROADWAY SUITE 950 DENVER CO 80202 720 697 5200
BioScrip, Inc. (Filer) CIK: 0001014739 (see all company filings)

IRS No.: 050489664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11993 | Film No.: 17771550
SIC: 8082 Services-Home Health Care Services